← Back to Search

Nitric Oxide Donor

Nitric Oxide for Liver Cirrhosis

Phase 1

Waitlist Available

Research Sponsored by National Center for Research Resources (NCRR)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cirrhotic patients with ascites with functional renal failure

Cirrhotic patient with ascites without renal failure

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is to see if nitric oxide affects blood pressure & kidney function in people with cirrhosis, compared to healthy subjects. 30 patients & 10 healthy subjects will be enrolled.

Who is the study for?

This trial is for adults with cirrhosis, a condition where the liver is scarred and doesn't work properly. It includes those with fluid buildup in the abdomen (ascites) but no kidney failure, as well as healthy individuals for comparison. People can't join if they have renal failure or other conditions not listed here.Check my eligibility

What is being tested?

The study investigates whether nitric oxide, a compound made by the body, affects blood pressure and kidney function in cirrhosis patients compared to healthy subjects. A total of 30 patients with cirrhosis and 10 healthy people will be enrolled.See study design

What are the potential side effects?

Since this trial seems to focus on observation rather than administering drugs or therapies directly related to nitric oxide levels, specific side effects are not detailed; however, general risks may include discomfort from testing procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have cirrhosis with fluid in my abdomen and kidney issues.

Select...

I have cirrhosis with fluid in my abdomen but no kidney failure.

Select...

I have cirrhosis but have never had swelling or fluid build-up.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 3Eligibility criteria met

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Center for Research Resources (NCRR)Lead Sponsor

537 Previous Clinical Trials

317,016 Total Patients Enrolled

4 Trials studying Liver Cirrhosis

436 Patients Enrolled for Liver Cirrhosis

Media Library

Nitric Oxide (Nitric Oxide Donor) Clinical Trial Eligibility Overview. Trial Name: NCT00005107 — Phase 1

Liver Cirrhosis Clinical Trial 2023: Nitric Oxide Highlights & Side Effects. Trial Name: NCT00005107 — Phase 1

Nitric Oxide (Nitric Oxide Donor) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00005107 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What adverse risks are associated with this treatment?

"The pre-existing data on this treatment's efficacy and safety is sparse, so it earned a scored of 1."

Answered by AI

Is there an age ceiling for joining this analysis?

"Prospective participants in this trial must be between the ages of 18 and 70. Concurrently, there are 76 studies for those younger than eighteen years old and 428 that cater to senior citizens over 65."

Answered by AI